Keyword: Allogene

Allogene biotech investments

5. Allogene Therapeutics

Allogene started life with a suite of ready-made candidates—along with a whopping $300 million series A round and former Kite Pharma executives Arie Belldegrun and David Chang as co-founders.
Total annual biotech investments

Biotech's top 10 money raisers of 2018

Private biotechs raised a record-breaking $16.8 billion in 2018, blowing past the record $12.1 billion set the previous year. Here are the top 10 fundraising rounds—which broke some records themselves and together illustrate what's hot out there in the field.